Printed from Voxsanity (voxsanity.com.au) — NCT06190665 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Liver Cancer
Liver Cancer Trial, Recruiting
NCT06190665
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with liver cancer (hepatocellular carcinoma) at a specific stage range, need a procedure called TACE (where medicine is delivered directly to the tumor through blood vessels), and are not able to have or have chosen not to have surgery, a liver transplant, or tumor ablation
- Your liver is functioning at a reasonably healthy level (rated Child-Pugh A or B — confirm with trial site)
- You are able to carry out basic daily activities, or have only mild limitations (rated 0–2 on a standard activity scale — confirm with trial site)
- You have at least one measurable tumor that has not previously been treated with embolization, and the largest tumor measures 10cm or less
- You are willing to take part and have signed a consent form agreeing to join the trial
Who may not be able to join:
- Your target tumor(s) have already been treated with embolization, or you will need ablation or radiation alongside or after the TACE treatment
- Your liver cancer has spread widely throughout the liver or to other parts of the body, and your expected survival is less than 6 months
- You have a serious whole-body infection or multiple organ failure
- Your liver or kidneys are severely damaged (confirm with trial site for specific test values)
- You have very low levels of white blood cells, platelets, or red blood cells that cannot be treated or corrected (confirm with trial site for specific values)
- You have a blood clotting problem that cannot be corrected (confirm with trial site)
- You have a serious active infection with a very high white blood cell count (confirm with trial site)
- The main blood vessel supplying your liver (portal vein) is completely blocked by the tumor with no alternative blood flow routes
- There is a risk of the treatment accidentally blocking blood flow in the wrong area due to an abnormal connection between blood vessels that has not been corrected
- Your blood vessel structure makes it difficult or impossible to safely place the required tube (catheter) or deliver the treatment
- You have a known allergy to iodine-based dyes used in scans, certain embolic materials (polyvinyl alcohol), or a type of chemotherapy drug called anthracyclines
- You are pregnant or currently breastfeeding
- You are already taking part in another clinical trial
- The trial doctors have decided for other reasons that participation would not be appropriate for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongda Hospital
Registry
ClinicalTrials.gov
Start date
19 December 2023
Est. completion
31 December 2025
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Disease control rate (DCR) for target lesions 1 month after the last TACE treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.